Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lantheus Holdings Inc LNTH

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company. The Company is engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic... see more

Recent & Breaking News (NDAQ:LNTH)

Lantheus Holdings, Inc. Reports 2017 First Quarter Financial Results; Exceeds First Quarter and Raises Full-Year 2017 Guidance

Business Wire May 2, 2017

Investor Network: Lantheus Holdings Inc. to Host Earnings Call

Accesswire May 2, 2017

Lantheus and GE Healthcare Announce the Signing of a Definitive License Agreement for Worldwide Development and Commercialization of Flurpiridaz F 18

Business Wire April 25, 2017

Lantheus Announces Refinancing of its Debt Facility

Business Wire March 30, 2017

Lantheus Holdings, Inc. Announces Public Secondary Offering of 3,000,000 Shares of Common Stock by Selling Stockholders

Business Wire March 13, 2017

Research Reports Initiation on Medical Equipment Stocks -- Lantheus, Cynosure, Natus Medical, and NovoCure

PR Newswire February 23, 2017

Mid-Afternoon Market Update: Microbot Medical Climbs Amid Technology Patent Allowance; Servicesource International Shares Tumble

Benzinga.com  February 22, 2017

18 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  February 22, 2017

Mid-Day Market Update: Crude Oil Down 1.5%; Lantheus Shares Surge Following Q4 Results

Benzinga.com  February 22, 2017

Mid-Morning Market Update: Markets Open Lower; DISH Network Profit Beats Expectations

Benzinga.com  February 22, 2017

Lantheus Holdings, Inc. Reports 2016 Fourth Quarter and Full Year Financial Results; Provides 2017 Guidance

Business Wire February 21, 2017

Lantheus Holdings and GE Healthcare Announce the Signing of a Term Sheet for Worldwide Development and Commercialization of Flurpiridaz F 18

Business Wire February 21, 2017

Lantheus Holdings to Host Fourth Quarter and Full Year 2016 Earnings Conference Call and Provide 2017 Guidance on February 21, 2017 at 4:30 p.m. Eastern Time

Business Wire February 7, 2017

Lantheus Medical Imaging Announces FDA Approval of DEFINITY® Label Update

Business Wire February 2, 2017

Lantheus Holdings Appoints New Member to its Board of Directors

Business Wire January 26, 2017

Research Reports Initiation on Medical Equipment Stocks -- Lantheus, Nevro, Steris, and Spectranetics

PR Newswire December 28, 2016

Technical Reports on Medical Equipment Equities -- Lantheus, Nevro, Steris, and Spectranetics

PR Newswire November 21, 2016

12 Biggest Mid-Day Losers For Wednesday

Benzinga.com  November 16, 2016

Lantheus Holdings, Inc. Announces Upsize of Public Offering to 3,500,000 Shares of Common Stock

Business Wire November 15, 2016

Lantheus Holdings, Inc. Announces Public Offering of 3,000,000 Shares of Common Stock

Business Wire November 15, 2016